Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells
Open Access
- 23 October 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 85 (1), 165-174
- https://doi.org/10.1189/jlb.0608383
Abstract
The Src homology‐2‐containing protein‐tyrosine phosphatase 1 (SHP‐1), is a negative regulator of cell signaling. It is also considered a tumor suppressor gene because of its ability to antagonize the action of tyrosine kinases. Although SHP‐1 is expressed strongly in hematopoietic cells, decreased expression has been observed in various hematological malignancies, which suggests a central involvement of SHP‐1 in leukemogenesis. We have shown previously that human T cell lymphotropic virus type‐1 (HTLV‐1) Tax‐induced promoter silencing (TIPS) is an early event causing down‐regulation of SHP‐1 expression, which is dependent on NF‐κB. In this study, DNase I footprinting and EMSA also revealed binding of transcription factors, specificity protein 1 (Sp1) and octamer‐binding transcription factor 1 (Oct‐1) to the P2 promoter, and site‐directed mutagenesis confirmed that these factors contribute to the basal P2 promoter activity. Chromatin immunoprecipitation (CHIP) assays showed that Sp1, Oct‐1, NF‐κB, CREB‐1, and RNA polymerase II interacted with the core SHP‐1 P2 promoter in CD4+ T cells and Jurkat cells but not in HTLV‐1‐transformed MT‐2 and HUT102 cells when HTLV‐1 Tax is present. Furthermore, bisulfite sequencing of the SHP‐1 P2 core region revealed heavy CpG methylation in HTLV‐1‐transformed cells compared with freshly isolated CD4+ T cells and HTLV‐1‐noninfected T cell lines. A significant inverse correlation between degree of CpG methylation and expression of SHP‐1 mRNA or protein was observed. Taken together, our data support the notion that in HTLV‐1‐transformed CD4+ T cells, TIPS causes dissociation of transcription factors from the core SHP‐1 P2 promoter, which in turn leads to subsequent DNA methylation, an important early step for leukemogenesis.Keywords
Funding Information
- NIH (CA104936, AI058804)
- National Foundation for Cancer Research
This publication has 36 references indexed in Scilit:
- Negative regulation of the SH2-homology–containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoproteinBlood, 2007
- Decreased expression level of SH2 domain‐containing protein tyrosine phosphatase‐1 (Shp1) is associated with progression of chronic myeloid leukaemiaThe Journal of Pathology, 2007
- PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic CellsOnline Journal of Public Health Informatics, 2007
- Protein-tyrosine phosphatases and cancerNature Reviews Cancer, 2006
- Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphomaBone Marrow Transplantation, 2005
- SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factorBritish Journal of Haematology, 2005
- Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesisBlood, 2005
- Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells: Implications for lymphomagenesisExperimental Hematology, 2003
- SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signalingLeukemia, 2002
- Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6)Genomics, 1992